People: Bristol-Myers Squibb Co (BMY)

BMY on New York Consolidated

62.46USD
26 Jan 2015
Change (% chg)

-- (--)
Prev Close
$62.46
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
6,825,695
52-wk High
$64.44
52-wk Low
$46.30

Search Stocks

Andreotti, Lamberto 

Brief Biography

Mr. Lamberto Andreotti has been appointed as Non-Executive Chairman of the Board of Bristol-Myers Squibb Company effective August 3, 2015. He has served as Executive Chairman of the Board of the Company from May 5, 2015 to August 3, 2015. He is no longer Chief Executive Officer of the Company effective May 5, 2015. He was Chief Executive Officer, Director of Bristol-Myers Squibb Company. Mr. Andreotti has been Chief Executive Officer since May 2010. He was our President and Chief Operating Officer from March 2009 to May 2010. From March 2008 to March 2009, Mr. Andreotti served as Executive Vice President and Chief Operating Officer of BMS. From May 2007 until March 2008, he served as Executive Vice President of BMS and Chief Operating Officer of Worldwide Pharmaceuticals, a division of BMS. Mr. Andreotti served as Executive Vice President of BMS and President of Worldwide Pharmaceuticals from 2005-2007 and as Senior Vice President and International President of Worldwide Pharmaceuticals from 2002-2005. He is a member of Pharmaceutical Research and Manufacturers of America and The Business Council.

Basic Compensation

Total Annual Compensation, USD Long-Term Incentive Plans, USD All Other, USD Fiscal Year Total, USD
5,486,450 -- 774,396 20,847,700

Options Compensation

  Quantity Market Value
Exercisable 242,193 --
Unexercisable 323,333 --
Exercised 30,000 39,300.00
Name Fiscal Year Total

James Cornelius

10,859,000

Charles Bancroft

7,878,020

Louis Schmukler

--

Giovanni Caforio

3,301,850

Francis Cuss

3,719,040

Paul von Autenried

--
As Of 30 Dec 2013
Search Stocks